Immix... recnac latceroloc ni 011-XMI r-

Current Location: Home >Markets >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-06-14 18:08:53 Source: Author: Careers & Partnerships Views: 442

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: Markets)

[1]

[2]

[3]

Previous: TRON... mooB elaserP )VRCT( evrucedarT
Next: World's... scisyhp wen kcolnu dluoc taht